The insulin-releasing ability and uptake characteristics of non-metabolizable, transport-specific amino acids were studied in an in vitro system, using microdissected pancreatic islets with more than 9 ° O//o/~-cells.
INTRODUCTION
The use of non-metabolizable model amino acids has been instrumental to the discrimination of specific transport systems in various cells 1. For example, ~-aminoisobutyrie acid was developed as a model substrate for transport System A, 2-aminobicyclo(2,2,i)heptane-2-carboxylic acid (BCH) as a leucine analogue with specificity for System L, and 4-amino-I-guanylpiperidine-4-carboxylic acid (GPA) as a model substrate for the system for cationic amino acids. The first of these was observed under certain conditions to stimulate the release of insulin from cultivated fetal pancreas (A. E. RENOLD et al., personal communication to H. N. CHRISTENSEN, 1968 ) ; the second substance was concurrently found to exert a hypoglycemic action 2,5 and to elevate the level of immunologically reactive insulin1, ~ in the intact rat. Subsequently, the amino acid was shown to behave as a functional analogue of leucine in stimulating the rise of the plasma insulin level in the dog 3. More recently, GPA has been shown to stimulate increase of the plasma levels of both insulin and glucagon in the rat 1 and the dog (S. S. FAJANS, H. S. CHRISTENSEN et al., unpublished work).
Several natural amino acids, including leucine, are known to stimulate the in vitro release of insulin. It seemed therefore reasonable to attribute the effects of BCH to a direct action on the pancreatic/3-cells. Since, furthermore, these model amino acids were designed as transport-specific substrates, insulin release was suggested to be triggered by the binding of amino acids to their specific transport molecules in the fl-cell membrane 2.
In the present paper, we test this hypothesis by studying the insulin-releasing potency of different BCH stereoisomers and of GPA in vitro. In addition, it was checked whether the pancreatic fl-cells are able to transport these model substrates. To obtain results representative of the //-cells, islets were microdissected from obesehyperglycemic mice. These islets contain more than 9 ° % fl-cells, which are known to respond adequately to all secretagogues tested including natural amino acids such as leucine and arginine.
MATERIALS AND METHODS

Chemicals
The synthesis, 1~C labelling and resolution of BCH were done as previously described a, 5. Synthesis and 1~C labelling of GPA will be described elsewhere by one of us (H.N.C.). EI-3HlMannitol and E6,6'-3H21sucrose were obtained from the Radiochemical Centre, Amersham, England. Crystalline mouse insulin was prepared by Novo Industri A/S, Copenhagen, Denmark. All other chemicals were commercially available reagents of analytical grade. Distilled and de-ionized water was used throughout.
Isolation of islets
Adult obese-hyperglycemic mice (gene symbol: obob) from the Ume£ colony were starved overnight. Fresh pancreatic islets were isolated by free-hand microdissection 6 in Krebs-Ringer buffer including 0.3-0.5 % (w/v) human serum albumin and equilibrated with 02-C02 (95:5, v/v).
Incubations
All incubations were performed at 37 °, using Krebs-Ringer buffer as basal medium. In studies of insulin release, incubation was first performed for 4 ° min. Batches of 2 islets were then incubated in I15 #1 medium for a short initial period of 5 rain (early phase) followed by incubation for 60 min (late phase) in 315/,1 medium. The amounts of insulin released were measured in samples of medium taken from the three incubation periods, allowing correction for insulin present in a minimum volume left from the preceding incubation period. Details of experiments are given in the legends to figures and tables.
In studies of amino acid uptake, islets were first incubated in basal medium. Batches of IO islets were subsequently incubated with radioactive amino acid. In some experiments the medium also contained Ei-3Hlmannitol or [6,6'-aH2 ]sucrose, which made it possible to correct for contaminating label and label in the extracellular space (B, HELLMAN, J. SEHLIN AND I.-B. T-KLJEDAL, unpublished work). When extracellular markers were not used, the incubated islets were washed for 4 × i rain in ice-cold, non-radioactive medium v. The detailed composition of incubation media as well as the length of incubation times are given in the legends to figures and tables.
Insulin assay
Insulin was assayed with the double-antibody method 8, using crystalline mouse insulin as standard.
Determination of amino acid uptake
After weighing (see below), the incubated islets were dissolved by incubation at room temperature in IOO #I of hyamine for 45 min. After addition of IO ml scintillation liquid (5 g of 2,5-diphenyloxazole and 5 ° mg 1,4-bis-2-(5-phenyl-oxazolyl)benzene in I 1 of toluene), counting was carried out in a liquid scintillation spectrometer. The observed counts/min values were translated to mmoles of labelled substrate by comparison with external standards counted in parallel with the islets. These standards consisted of 5 #1 incubation medium dissolved in ioo/~1 of hyamine. In double-label experiments the setting of the discriminators was such that less than 0.5 % of the 3H counts were also counted in the 14C channel. Spill-over to the 3H channel was 25 % of the counts in the 14C channel. The specific radioactivities were chosen to give approximately the same counts/min in either channel.
Weighing of islets
Incubated islets were placed on bits of aluminium foil and were gently freed of as much contaminating fluid as possible with the aid of a micropipette. After freeze-drying (--4 o°, o.ooi mm Hg) overnight, the islets were weighed on a quartzfibre balance 9.
RESULTS
Experiments with BCH
As shown in Table I 
TABLE I EFFECTS OF a(±)-BCH AND b(±)-BCH ON INSULIN RELEASE
Amounts of insulin released during 6o min of incubation are given as mean values -4-S.E. for the numbers of experiments indicated within parentheses. In each experiment islets from a single animal were incubated with 5 or io mM BCH as well as in a ]3CH-free control medium. A statistical test of the mean differences between test and control media revealed that b(:~)-]3CH had a significant effect both in the absence (5 raM: P < o.o5; io raM: P < o.ooi) and in the presence (io mM: P < 0.02) of glucose. 
Experiments with GPA
The effect of GPA on insulin release is presented in Table III . When tested at a concentration of 5 mM, the arginine analogue failed to enhance insulin release. A probably significant stimulation was, however, noted after 60 rain of incubation with IO mM GPA in the presence of IO mM glucose. Results are presented as in Table II . The effect of io mM GPA in the presence of io mM glucose was probably significant (P<o.o5) during the late phase. 3 shows that the islet cells were able to accumulate GPA to yield distribution ratios much higher than unity. It should be noted that identical results were obtained irrespective of whether washing or double-labelling was used to correct for extracellular and contaminating radioactivity.
Glucose cohen, ng insulin released per I~g dry islet (raM)
DISCUSSION
Several amino acids are able to stimulate insulin release 1°. Most of these, including arginine, do so in the presence of glucose, whereas leucine acts as a secretagogue also in glucose-free media n. The in vivo action of BCH resembles that of leucine and contrasts with that of arginine in persisting when mannoheptulose has been infused 3. Its hypoglycemic action was found to be limited to the b(-)-isomer of BCH', 5,1~. The mechanism by which amino acids stimulate insulin release is not clear. The action of BCH in vivo indicates that the secretory response of the fl-cells does not require metabolism of the amino acid1, 2 (cf. ref. IO). As an alternative hypothesis, CHRISTENSEN AND CULLEN 2 suggested that insulin release is triggered by the binding of amino acids to specific transport molecules in the fl-cell membrane.
The present in vitro study was undertaken to elucidate the following problems that arise as a consequence of the above hypothesis. (I) Is BCH-induced hypoglycemia due to a primary effect on the fl-cells? (2) Are the fl-cells stimulated by other transport-specific amino acids? (3) Is there a difference in insulin-releasing activity between the four stereo-isomers of BCH? (4) Is there a correlation between the insulinreleasing activity of different BCH isomers and their uptake characteristics?
A direct effect of BCH on fetal rat pancreas has recently been described 13. This pancreas preparation differs, however, from adult islets in its sensitivity to various amino acids. For example, islets of obese-hyperglycemic mice are not stimulated by alanine or a-aminoisobutyric acid (A. Lernmark, unpublished work), whereas these amino acids are potent secretagogues with the fetal rat pancreas preparation la, 1~. Amino acids, not including BCH or leucine a, are also known to stimulate the release of glucagonl0,15, which is in turn an insulin secretagogue. In the present study advantage was taken of the unusually low proportion of s-cells in the microdissected islets of obese-hyperglycemic mice 1~. Our results are therefore most probably representative for the fi-cells and support the idea that BCH exerts a direct stimulatory action on these cells.
If the hypothesis of CHRISTENSEN AND CULLEN 2 is correct, one would expect a transport-specific arginine analogue to mimick arginine also as an insulin secretagogue. Circumstantial evidence that this is the case has been obtained by measuring plasma insulin in GPA-injected rats ~ and dogs (S. S. FAJANS, H. N. CHRISTENSEN et al., unpublished work). From the present results it is clear that GPA is taken up by the islet cells and that it stimulates insulin release in vitro. The glucose dependency of GPA as an insulin secretagogue contrasts with the glucose independency of b(-)-BCH and supports the idea that GPA acts by the same mechanism as arginine. Tile fact that glucose also potentiates the effect of glucagon on insulin release 17 stresses the question whether the effect of GPA might be fully explained by its action as a glucagon secretagogue 1. This possibility seems most unlikely, however, in view of the very low proportion of a-cells in the present islets TM. A racemic mixture of b(+)-BCH and b( --)-BCH stimulated insulin release significantly, whereas a similar mixture of a(+)-BCH and a(--)-BCH was without effect.
It seems therefore unlikely that the a(+)-isomers contribute to the hypoglycemic action of BCH. After resolution of the individual b-isomers, it was evident that only b(--)-BCH was effective as a stimulus of insulin release. With the latter isomer there was a significant enhancement of insulin release both in the absence and in the presence of glucose. In this respect, the behaviour of b( -)-BCH is strikingly similar to leucine.
The structure of BCH was originally designed to provide a sufficiently bulky "side-chain" to keep it out of transport systems other than L. An incidental consequence of its structure is that the molecule not only escapes degradation but is subject to rather little distortion. The recognition site for insulin release obviously finds these characteristics no significant handicap and responds almost as though BCH were leucine; hence we are led to say that this recognition site resembles a transport site in not requiring that the "substrate" be either destabilized or distorted. It also resembles a transport site in finding only one of the four possible dispositions of the sidechain mass of BCH suitable to a response, namely that shown by the isomer b(-).
This isomer is the only one that shows measurable uptake by Escherichia coli, utilizing a transport system serving for leucine, isoleucine and valine 1. The same isomer tends to have the most rapid uptake by various cells and tissues, and only it is regarded as a fully characteristic substrate of the so-called L system. Nevertheless, b(+) and b(-) were taken up about equally rapidly by the isolated islets. In certain other tissues the a(+)-isomer has been shown in the Michigan laboratory to be transported approximately as well as the b(-)-isomer. We may of course question whether the same receptor site is involved for the two isomers in the two cases.
Because not much is known of recognition sites other than transport sites that need not degrade and perhaps not even to distort the substrate, it has been tempting to conclude that the site signalling insulin release is a transport receptor site, or is evolved from a transport receptor site s. This proposal did not specify which consequence of entry of a solute into a transport site might produce the signal, but presumably the response of the site, perhaps an induced fit to the substrate or a modification of conformational relations among participating macromolecules, is necessary to a signal. The circumstance that we now have uncovered an arginine-like insulin releasing agent in the first model substrate constructed for the transport system for cationic amino acids, and that this substrate is transported vigorously into the islet, encourages the same viewpoint. In the absence of a perfect correspondence between the amino acids that are transported and those that stimulate insulin release, however, only detailed analysis of the effector system can establish the hypothesis. For the present its main merit may be to provide us with a provisional example of the kind of recognition site needed to explain the signalling for insulin release.
